Cabergoline (Dostinex) is an oral medication available in tablet form, with each tablet containing 0.5mg of cabergoline. It is primarily used to treat disorders related to high levels of the hormone prolactin, such as prolactinomas, and to manage conditions like hyperprolactinemia.

Instructions for Use:

1. Composition: Each package contains 8 tablets, with each tablet containing 0.5mg of cabergoline.
2. Dosage: The dosage is typically tailored to the individual, based on the condition being treated and the patient’s response. Commonly, treatment starts with a low dose, gradually increasing as needed. Consult with a healthcare professional for personalized dosage recommendations.
3. Administration: Take the tablets orally with water, usually twice a week, or as directed by your healthcare provider. It is often recommended to take cabergoline with food to reduce the likelihood of gastrointestinal discomfort.
4. Monitoring: Regularly monitor prolactin levels and other relevant health markers as directed by your healthcare provider to assess the effectiveness of the treatment.
5. Potential Side Effects: Common side effects may include nausea, dizziness, headaches, and fatigue. In rare cases, more serious side effects such as heart valve issues or psychiatric symptoms may occur. Report any unusual or severe side effects to your healthcare provider promptly.
6. Special Considerations: Use with caution in patients with a history of cardiovascular disease, particularly those with issues related to heart valves. Inform your healthcare provider of any other medications or supplements you are taking.
7. Interactions: Cabergoline may interact with other medications, particularly those that affect dopamine levels. Ensure your healthcare provider is aware of all medications you are currently taking.
8. Storage: Store the tablets in a cool, dry place away from direct sunlight and moisture.

Consultation Reminder: Always consult with a healthcare professional before using cabergoline to ensure safe and appropriate use, particularly in managing hormone-related conditions.